Andrade-Vieira, R., Goguen, D., Bentley, H. A., Bowen, C. V., & Marignani, P. A. (2014). Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss. Oncotarget.

Andrade-Vieira, Rafaela, Donna Goguen, Heidi A. Bentley, Chris V. Bowen, and Paola A. Marignani. "Pre-clinical Study of Drug Combinations That Reduce Breast Cancer Burden Due to Aberrant MTOR and Metabolism Promoted By LKB1 Loss." Oncotarget 2014.

Andrade-Vieira, Rafaela, et al. "Pre-clinical Study of Drug Combinations That Reduce Breast Cancer Burden Due to Aberrant MTOR and Metabolism Promoted By LKB1 Loss." Oncotarget 2014.